Energy Balance in Hypothalamic Obesity in Response to Treatment with a Once-Weekly GLP-1 Receptor Agonist

BACKGROUND/OBJECTIVES: Hypothalamic obesity (HO) frequently occurs following suprasellar tumors from a combination of decreased energy expenditure and increased energy intake. Glucagon-like peptide-1 receptor agonist (GLP1RA) therapy is associated with increased satiety and energy expenditure. We hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoemaker, Ashley H., Silver, Heidi J., Buchowski, Maciej, Slaughter, James C., Yanovski, Jack A., Elfers, Clinton, Roth, Christian L., Abuzzahab, M. Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881399/
https://www.ncbi.nlm.nih.gov/pubmed/34975146
http://dx.doi.org/10.1038/s41366-021-01043-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881399/
https://www.ncbi.nlm.nih.gov/pubmed/34975146
http://dx.doi.org/10.1038/s41366-021-01043-6

Ejemplares similares